Associated Papers
Evaluation of the synapse adhesion molecule Kirrel3 in neurological disease.
Shennib O et al.
Frontiers in Neurology, 2025
Pan-cancer assessment of mutational landscape in intrinsically disordered hotspots reveals potential driver genes.
Zou H et al.
Nucleic Acids Research, 2022
35061901 (PubMed )
Supplement: gkac028_supplemental_files.zip › Table_S3_new.xlsx › Sheet1
Single-cell transcriptome identifies molecular subtype of autism spectrum disorder impacted by de novo loss-of-function variants regulating glial cells.
Nassir N et al.
Human Genomics, 2021
34802461 (PubMed )
Supplement: 40246_2021_368_MOESM2_ESM.xlsx › DbMS-non_synonymous_ex
Kirrel3-Mediated Synapse Formation Is Attenuated by Disease-Associated Missense Variants.
Taylor MR et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience, 2020
De novo genic mutations among a Chinese autism spectrum disorder cohort.
Wang T et al.
Nature Communications, 2016
27824329 (PubMed )
Supplement: ncomms13316-s7.xlsx › Supplementary_Data_6
Genome-wide characteristics of de novo mutations in autism.
Yuen RK et al.
Npj Genomic Medicine, 2016
27525107 (PubMed )
Supplement: npjgenmed201627-s3.xlsx › Table_S10
Patients with genetically heterogeneous synchronous colorectal cancer carry rare damaging germline mutations in immune-related genes.
Cereda M et al.
Nature Communications, 2016
27377421 (PubMed )
Supplement: ncomms12072-s2.xlsx › UH11T1
Select a paper to view details